Ovid Therapeutics
OVID
OVID
72 hedge funds and large institutions have $113M invested in Ovid Therapeutics in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
23% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 26
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
44% less call options, than puts
Call options by funds: $1.17M | Put options by funds: $2.09M
Holders
72
Holding in Top 10
1
Calls
$1.17M
Puts
$2.09M
Top Buyers
| 1 | +$4.21M | |
| 2 | +$1.31M | |
| 3 | +$1.24M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.12M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$337K |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$1.19M | |
| 3 | -$1.18M | |
| 4 |
Two Sigma Investments
New York
|
-$1.13M |
| 5 |
Two Sigma Advisers
New York
|
-$754K |